BRIEF published on 02/07/2025 at 15:53, 1 year 6 months ago Sartorius AG propose un dividende pour 2024 Exercice 2024 Assemblée Générale Annuelle Actualités Financières Proposition De Dividende Sartorius SA
BRIEF published on 02/07/2025 at 15:53, 1 year 6 months ago Sartorius AG Proposes Dividend for 2024 Annual General Meeting Financial News Dividend Proposal Sartorius AG 2024 Fiscal Year
PRESS RELEASE published on 02/07/2025 at 15:48, 1 year 6 months ago The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share for fiscal 2024. Dividend payment on April 1, 2025 Annual General Meeting Dividend Supervisory Board Sartorius AG Preference Share
BRIEF published on 01/28/2025 at 07:05, 1 year 6 months ago Sartorius annonce une clôture positive pour l'exercice 2024 Chiffre D'affaires Exercice 2024 Prévisions De Croissance Sartorius SA Marge Bénéficiaire
BRIEF published on 01/28/2025 at 07:05, 1 year 6 months ago Sartorius Reports Positive Closing for Fiscal 2024 Fiscal 2024 Sales Revenue Sartorius AG Growth Forecast Profit Margin
PRESS RELEASE published on 01/28/2025 at 07:00, 1 year 6 months ago Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved Sartorius closes fiscal 2024 with stable sales revenue and positive trend, meeting full-year guidance. Order intake up; cautiously optimistic outlook for 2025 Fiscal 2024 Sartorius Sales Revenue Full-year Guidance Outlook 2025
BRIEF published on 12/06/2024 at 18:26, 1 year 8 months ago Michael Grosse nommé nouveau PDG de Sartorius AG Industrie Biopharmaceutique Transition Du PDG Sartorius SA Joachim Kreuzburg Michael Grosse
BRIEF published on 12/06/2024 at 18:26, 1 year 8 months ago Michael Grosse Appointed as New CEO of Sartorius AG CEO Transition Sartorius AG Biopharma Industry Joachim Kreuzburg Michael Grosse
BRIEF published on 12/06/2024 at 18:22, 1 year 8 months ago Michael Grosse Appointed as CEO of Sartorius AG CEO Appointment Leadership Transition Sartorius AG Biopharmaceutical Industry Michael Grosse
BRIEF published on 12/06/2024 at 18:22, 1 year 8 months ago Michael Grosse nommé PDG de Sartorius AG Industrie Biopharmaceutique Transition De Direction Nomination Du PDG Sartorius SA Michael Grosse
Published on 08/07/2026 at 23:15, 2 days 8 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 8 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 9 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 9 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 07:30, 28 minutes ago GEA second quarter figures: Double-digit growth in order intake and revenue, with significantly higher profitability
Published on 08/10/2026 at 07:29, 28 minutes ago EQS-Adhoc: q.beyond accelerates AI transformation and adjusts outlook for 2026 financial year
Published on 08/10/2026 at 07:10, 48 minutes ago Hypoport delivers solid gross profit growth and marked EBIT increase in first half of 2026
Published on 08/10/2026 at 07:00, 58 minutes ago Infracore SA announces partial exercise of the over-allotment option
Published on 08/10/2026 at 07:00, 58 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 58 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Published on 08/07/2026 at 18:54, 2 days 13 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 13 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 13 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
